The role of iron in mitigating erythropoietic porphyrias is further underlined by the description of a patient with erythropoietic protoporphyria caused by combination of mutations in CLPX and in the IRE domain of ALAS2 [44]. The gene discussed is ALAS2; the disease is cutaneous porphyria.